OGMIX
Price
$33.41
Change
+$1.00 (+3.09%)
Updated
Apr 10 closing price
Net Assets
2.34B
OGMYX
Price
$33.08
Change
+$0.99 (+3.09%)
Updated
Apr 10 closing price
Net Assets
2.34B
Ad is loading...

OGMIX vs OGMYX

Header iconOGMIX vs OGMYX Comparison
Open Charts OGMIX vs OGMYXBanner chart's image
Invesco Gold & Special Minerals R6
Price$33.41
Change+$1.00 (+3.09%)
VolumeN/A
Net Assets2.34B
Invesco Gold & Special Minerals Y
Price$33.08
Change+$0.99 (+3.09%)
VolumeN/A
Net Assets2.34B
OGMIX vs OGMYX Comparison Chart
Loading...
View a ticker or compare two or three
VS
OGMIX vs. OGMYX commentary
Apr 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OGMIX is a Buy and OGMYX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
OGMIX (2.34B) and OGMYX (2.34B) have equal amount of cash in the bank . OGMIX pays higher dividends than OGMYX: OGMIX (0.92) vs OGMYX (0.80). OGMIX was incepted earlier than OGMYX: OGMIX (12 years) vs OGMYX (15 years). OGMYX (0.86) is less costly to investors than OGMIX (0.69). OGMIX (30.00) and OGMYX (30.00) have comparable annual turnover. OGMYX has a lower initial minimum investment than OGMIX: OGMYX (1000) vs OGMIX (1000000). OGMIX (31.31) and OGMYX (31.15) have marching annual gain over last year. OGMIX (83.26) and OGMYX (81.82) have equivalent 5 years return.
OGMIXOGMYXOGMIX / OGMYX
Total Expense Ratio0.690.8680%
Annual Report Gross Expense Ratio0.690.8680%
Fund Existence12 years15 years-
Gain YTD24.84624.815100%
Front LoadN/AN/A-
Min. Initial Investment10000001000100,000%
Min. Initial Investment IRAN/AN/A-
Net Assets2.34B2.34B100%
Annual Yield % from dividends0.920.80115%
Returns for 1 year31.3131.15101%
Returns for 3 years11.0710.53105%
Returns for 5 years83.2681.82102%
Returns for 10 years196.27191.65102%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HAGIX68.58N/A
N/A
Carillon Eagle Mid Cap Growth I
MRJIX10.39N/A
N/A
Morgan Stanley Multi-Asset Real Return I
USEMX19.48N/A
N/A
Victory Emerging Markets
LMORX32.50N/A
N/A
Patient Opportunity R
TARKX24.20N/A
N/A
Tarkio